Skip to content

COMPARISION OF LAPAROSCOPIC AND ENDOSCOPIC DRAINAGE FOR PSEUDOCYST OF PANCREAS

A PROSPECTIVE RANDOMIZED TRIAL COMPARING LAPAROSCOPIC VERSUS ENDOSCOPIC DRAINAGE OF PSEUDOCYST of PANCREAS

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013573
Enrollment
34
Registered
2018-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pseudocyst/Walled off Necrosis of Pancreas following Acute Pancreatitis

Interventions

Intervention1: GROUP-I(LAPAROSCOPIC GROUP): LAPAROSCOPIC CYSTOGASTROSTOMY Control Intervention1: GROUP-II(ENDOSCOPIC GROUP): ENDOSCOPIC CYSTOGASTROSTOMY

Sponsors

ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with Pseudocyst/WON of Pancreas of >6cm size >6wks following Acute pancreatitis

Exclusion criteria

Exclusion criteria: Patients with chronic pancreatitis associated pseudocyst 2.Patients who had undergone any form of intervention previously 3.Patients with significant co-morbidities 4.Patients unfit for general anesthesia 5.Uncontrolled bleeding diasthesis 6.Patients refusing consent 7.Presence of arterial pseudoaneurysm 8.Patients with psuedocyst/WON located away from the stomach/duodenum 9.Patients with WON comprising of mostly solid debris 10.Patients with portal hypertension 11.Patients with obstructive jaundice with serum t.bilirubin- >5mg/dl

Design outcomes

Primary

MeasureTime frame
Defined by cyst resolution by the intended modality after the index intervention and the secondary infection requiring re-intervention were co-primary outcomesTimepoint: 4 weeks

Secondary

MeasureTime frame
Complications such as infection, bleeding, perforation peritonitis requiring intervention Timepoint: 3 months;Conversion to the other mode of drainageTimepoint: 3 months;Number of procedures and hospital stay Recurrence rates during follow up Timepoint: 3 months

Countries

India

Contacts

Public ContactSURYALOK ANGADI

ALL INDIA INSTITUTE OF MEDICAL SCIENCES

pgarg10@gmail.com9810038116

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026